Unlike current treatments on the market for hereditary angioedema, navenibart requires dosing only every 3-6 months.

Ethicist Art Caplan discusses a recent ethical consult on whether a suicide note should influence the decision whether to ...

Professor David Kerr examines a massive meta-analysis raising questions about GLP-1 drugs and colorectal cancer risk in ...

Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.

A study of couples across four countries underscores partner inclusion, structured screening, and immediate referral to psycho-oncology to prevent maladaptive coping.

An AI tool could flag patients at risk for osteoporosis or osteopenia by evaluating standard hip and pelvis x-rays, new ...

Patients with a particular histopathologic phenotype may respond less well to rituximab, but it is still unclear what factors ...

Results from Asia suggest chronic rhinosinusitis is associated with an increased risk for cancer, but whether these results ...

A new machine learning model built using a simple and interpretable approach predicts in-hospital death in patients with ...

Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to pre-exposure prophylaxis (PrEP), based on data presented at ...

An 82-trial Cochrane review finds little difference in mortality, quality of life, or safety when nurses substitute for ...

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.